Harvard Management Company’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-541,124
| Closed | -$8.91M | – | 46 |
|
|
2023
Q1 | $8.91M | Hold |
541,124
| – | – | 0.94% | 18 |
|
|
2022
Q4 | $8.08M | Hold |
541,124
| – | – | 1% | 17 |
|
|
2022
Q3 | $12.1M | Hold |
541,124
| – | – | 1.51% | 10 |
|
|
2022
Q2 | $9.06M | Hold |
541,124
| – | – | 1.05% | 14 |
|
|
2022
Q1 | $16.2M | Hold |
541,124
| – | – | 1.63% | 8 |
|
|
2021
Q4 | $16.6M | Hold |
541,124
| – | – | 1.56% | 11 |
|
|
2021
Q3 | $17.1M | Hold |
541,124
| – | – | 1% | 14 |
|
|
2021
Q2 | $19.8M | Hold |
541,124
| – | – | 1.14% | 17 |
|
|
2021
Q1 | $18.7M | Hold |
541,124
| – | – | 1.05% | 16 |
|
|
2020
Q4 | $22.5M | Hold |
541,124
| – | – | 1.22% | 12 |
|
|
2020
Q3 | $23M | Buy |
+541,124
| New | +$23M | 1.27% | 10 |
|